Monika Bazanella1, Tanja V Maier2, Thomas Clavel3, Ilias Lagkouvardos3, Marianna Lucio2, Maria X Maldonado-Gòmez4, Chloe Autran5, Jens Walter6, Lars Bode5, Philippe Schmitt-Kopplin7,2, Dirk Haller8,3. 1. Chair of Nutrition and Immunology. 2. Research Unit Analytical Biogeochemistry, Helmholtz Center Munich, Oberschleißheim, Germany. 3. ZIEL - Institute for Food & Health, and. 4. Department of Food Science and Technology, University of Nebraska, Lincoln, NE. 5. Divisions of Neonatology and Gastroenterology, Hepatology, and Nutrition, Department of Pediatrics, and Larsson-Rosenquist Foundation Mother-Milk-Infant Center of Research Excellence (MoMICoRE), University of California, San Diego, La Jolla, CA. 6. Chair for Nutrition, Microbes and Gastrointestinal Health, University of Alberta, Edmonton, Alberta, Canada; and. 7. Chair of Analytical Food Chemistry, Technical University of Munich, Freising, Germany. 8. Chair of Nutrition and Immunology, dirk.haller@tum.de.
Abstract
Background: Early-life colonization of the intestinal tract is a dynamic process influenced by numerous factors. The impact of probiotic-supplemented infant formula on the composition and function of the infant gut microbiota is not well defined.Objective: We sought to determine the effects of a bifidobacteria-containing formula on the healthy human intestinal microbiome during the first year of life.Design: A double-blind, randomized, placebo-controlled study of newborn infants assigned to a standard whey-based formula containing a total of 107 colony-forming units (CFU)/g of Bifidobacterium bifidum, Bifidobacterium breve, Bifidobacterium longum, B. longum subspecies infantis (intervention), or to a control formula without bifidobacteria (placebo). Breastfed controls were included. Diversity and composition of fecal microbiota were determined by 16S ribosomal RNA gene amplicon sequencing, and metabolite profiles were analyzed by ultrahigh-performance liquid chromatography-mass spectrometry over a period of 2 y. Results: Infants (n = 106) were randomly assigned to either the interventional (n = 48) or placebo (n = 49) group; 9 infants were exclusively breastfed throughout the entire intervention period of 12 mo. Infants exposed to bifidobacteria-supplemented formula showed decreased occurrence of Bacteroides and Blautia spp. associated with changes in lipids and unknown metabolites at month 1. Microbiota and metabolite profiles of intervention and placebo groups converged during the study period, and long-term colonization (24 mo) of the supplemented Bifidobacterium strains was not detected. Significant differences in microbiota and metabolites were detected between infants fed breast milk and those fed formula (P < 0.005) and between infants birthed vaginally and those birthed by cesarean delivery (P < 0.005). No significant differences were observed between infant feeding groups regarding growth, antibiotic uptake, or other health variables (P > 0.05). Conclusion: The supplementation of bifidobacteria to infant diet can modulate the occurrence of specific bacteria and metabolites during early life with no detectable long-term effects. This trial was registered at germanctr.de as DRKS00003660.
RCT Entities:
Background: Early-life colonization of the intestinal tract is a dynamic process influenced by numerous factors. The impact of probiotic-supplemented infant formula on the composition and function of the infant gut microbiota is not well defined.Objective: We sought to determine the effects of a bifidobacteria-containing formula on the healthy human intestinal microbiome during the first year of life.Design: A double-blind, randomized, placebo-controlled study of newborn infants assigned to a standard whey-based formula containing a total of 107 colony-forming units (CFU)/g of Bifidobacterium bifidum, Bifidobacterium breve, Bifidobacterium longum, B. longum subspecies infantis (intervention), or to a control formula without bifidobacteria (placebo). Breastfed controls were included. Diversity and composition of fecal microbiota were determined by 16S ribosomal RNA gene amplicon sequencing, and metabolite profiles were analyzed by ultrahigh-performance liquid chromatography-mass spectrometry over a period of 2 y. Results:Infants (n = 106) were randomly assigned to either the interventional (n = 48) or placebo (n = 49) group; 9 infants were exclusively breastfed throughout the entire intervention period of 12 mo. Infants exposed to bifidobacteria-supplemented formula showed decreased occurrence of Bacteroides and Blautia spp. associated with changes in lipids and unknown metabolites at month 1. Microbiota and metabolite profiles of intervention and placebo groups converged during the study period, and long-term colonization (24 mo) of the supplemented Bifidobacterium strains was not detected. Significant differences in microbiota and metabolites were detected between infants fed breast milk and those fed formula (P < 0.005) and between infants birthed vaginally and those birthed by cesarean delivery (P < 0.005). No significant differences were observed between infant feeding groups regarding growth, antibiotic uptake, or other health variables (P > 0.05). Conclusion: The supplementation of bifidobacteria to infant diet can modulate the occurrence of specific bacteria and metabolites during early life with no detectable long-term effects. This trial was registered at germanctr.de as DRKS00003660.
Authors: Lianna F Wood; Bryan P Brown; Katie Lennard; Ulas Karaoz; Enock Havyarimana; Jo-Ann S Passmore; Anneke C Hesseling; Paul T Edlefsen; Louise Kuhn; Nicola Mulder; Eoin L Brodie; Donald L Sodora; Heather B Jaspan Journal: Clin Infect Dis Date: 2018-09-28 Impact factor: 9.079
Authors: Lauren R Brink; Kelly E Mercer; Brian D Piccolo; Sree V Chintapalli; Ahmed Elolimy; Anne K Bowlin; Katelin S Matazel; Lindsay Pack; Sean H Adams; Kartik Shankar; Thomas M Badger; Aline Andres; Laxmi Yeruva Journal: Am J Clin Nutr Date: 2020-06-01 Impact factor: 7.045
Authors: Jeffrey M Bender; Fan Li; Heena Purswani; Taylor Capretz; Chiara Cerini; Sara Zabih; Long Hung; Nicole Francis; Steven Chin; Pia S Pannaraj; Grace Aldrovandi Journal: J Matern Fetal Neonatal Med Date: 2019-11-19
Authors: Dominique G Bihan; Thomas Rydzak; Madeleine Wyss; Keir Pittman; Kathy D McCoy; Ian A Lewis Journal: PLoS One Date: 2022-04-20 Impact factor: 3.240